OCULNasdaq United States
Market cap
$2.018 B
$9.19 +5.15%
Close of 7 Aug 2026
Revenue
$52.0M
#2729 by revenue
Earnings
-$265.9M
Loss-making
Shares outstanding
219,615,868
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Ocular Therapeutix are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.